论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Zhu MY, Liu WJ, Wang H, Wang WD, Liu NW, Lu Y
Received 26 January 2019
Accepted for publication 20 April 2019
Published 17 May 2019 Volume 2019:11 Pages 4577—4595
DOI https://doi.org/10.2147/CMAR.S203010
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Cristina Weinberg
Peer reviewer comments 2
Editor who approved publication: Professor Nakshatri
Background/aims: Diffuse
large B-cell lymphoma (DLBCL) is a highly common type of malignant and
heterogeneous non-Hodgkin’s lymphoma. Tumor-associated macrophages, specially
the M2-type, promote tumor progression and drug resistance. The clinical
outcome of patients with high neuron-specific enolase (NSE) expression is worse
than that with low NSE expression. The tumor-promoting mechanism of NSE,
however, remains unclear. This study explored the role of NSE in macrophage
polarization associated with the immune microenvironment of DLBCL.
Results: Our
results showed that NSE protein expression was higher in lymphoma cell lines
than in the B lymphocytes. Functional studies demonstrated that upregulation of
NSE in lymphoma cells could promote M2 polarization and migration ability of
macrophage, thereby consequently promoting the progression of lymphoma in vitro
and in vivo. Further mechanism studies revealed that lymphoma-derived exosomes
could mediate NSE into macrophages, NSE enhanced nuclear p50 translocation with
subsequent defective classical nuclear factor-κB activity in macrophages.
Conclusions: These
results indicate that NSE may be a potential target for lymphoma therapy and a
prognosis marker for lymphoma.
Keywords: neuron-specific
enolase, diffuse large B-cell lymphoma, macrophage
